Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
7.51
+0.02 (0.27%)
At close: Feb 13, 2026, 4:00 PM EST
7.59
+0.08 (1.05%)
After-hours: Feb 13, 2026, 7:59 PM EST
Tilray Brands Market Cap
Tilray Brands has a market cap or net worth of $874.97 million as of February 13, 2026. Its market cap has decreased by -17.42% in one year.
Market Cap
874.97M
Enterprise Value
903.04M
1-Year Change
-17.42%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since May 4, 2021, Tilray Brands's market cap has decreased from $9.87B to $874.97M, a decrease of -91.13%. That is a compound annual growth rate of -39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 874.97M | -16.24% |
| Dec 31, 2025 | 1.04B | -13.05% |
| Dec 31, 2024 | 1.20B | -28.47% |
| Dec 29, 2023 | 1.68B | 2.13% |
| Dec 30, 2022 | 1.64B | -63.52% |
| Dec 31, 2021 | 4.51B | -54.31% |
| May 4, 2021 | 9.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alvotech | 1.45B |
| Collegium Pharmaceutical | 1.45B |
| Amphastar Pharmaceuticals | 1.31B |
| Evotec SE | 1.27B |
| Cronos Group | 998.00M |
| Pacira BioSciences | 936.57M |
| BioAge Labs | 817.10M |
| Esperion Therapeutics | 807.53M |